Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TERT | O14746 | 3/20 | 0.61 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.61 |
| ▸ | PPARG | P37231 | 3/20 | 0.61 |
| ▸ | PPARD | Q03181 | 3/20 | 0.61 |
| ▸ | PPARA | Q07869 | 3/20 | 0.61 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.61 |
| ▸ | MAPT | P10636 | 2/20 | 0.61 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.61 |
| ▸ | BLM | P54132 | 2/20 | 0.61 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.61 |
| ▸ | FABP4 | P15090 | 2/20 | 0.61 |
| ▸ | FAAH | O00519 | 2/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.61 |
| ▸ | GMNN | O75496 | 1/20 | 0.61 |
| ▸ | USP2 | O75604 | 1/20 | 0.61 |
| ▸ | LMNA | P02545 | 1/20 | 0.61 |
| ▸ | POLB | P06746 | 1/20 | 0.61 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.61 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.61 |
| ▸ | APEX1 | P27695 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26444130 | 1.00 | TERT (0.61) | TERTPTPN1PPARGPPARDPPARA | |
| SCHEMBL6744545 | 1.00 | TERT (0.61) | TERTPTPN1PPARGPPARDPPARA | |
| SCHEMBL25298084 | 0.96 | TERT (0.66) | TERTPTPN1PPARGPPARDPPARA | |
| SCHEMBL25298423 | 0.96 | TERT (0.66) | TERTPTPN1PPARGPPARDPPARA | |
| SCHEMBL25290915 | 0.96 | TERT (0.66) | TERTPTPN1PPARGPPARDPPARA | |
| SCHEMBL23041584 | 0.96 | TERT (0.66) | TERTPTPN1PPARGPPARDPPARA | |
| SCHEMBL25291566 | 0.96 | TERT (0.66) | TERTPTPN1PPARGPPARDPPARA | |
| SCHEMBL25287432 | 0.96 | TERT (0.66) | TERTPTPN1PPARGPPARDPPARA | |
| SCHEMBL25298092 | 0.96 | TERT (0.66) | TERTPTPN1PPARGPPARDPPARA | |
| SCHEMBL25287653 | 0.96 | TERT (0.66) | TERTPTPN1PPARGPPARDPPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240207410-A1 | STABILIZED LIQUID COMPOSITIONS COMPRISING A LEVODOPA-TYROSINE CONJUGATE AND USES THEREOF | NEURODERM, LTD. (IL) | 2024-06-27 | — | — | US | disclosed |
| EP-4305049-A1 | STABILIZED LIQUID COMPOSITIONS COMPRISING A LEVODOPA-TYROSINE CONJUGATE AND USES THEREOF | Neuroderm Ltd (IL) | 2024-01-17 | — | — | EP | disclosed |
| US-11844754-B2 | Methods for treatment of Parkinson's disease | NEURODERM, LTD. (IL) | 2023-12-19 | — | — | US | disclosed |
| CN-114507555-B | Biodegradable flame-retardant hydraulic oil composition | 中国石油化工股份有限公司 | 2023-08-08 | — | — | CN | disclosed |
| WO-2023126945-A1 | METHODS AND COMPOSITIONS FOR TREATING PARKINSON'S DISEASE | NEURODERM, LTD. (IL) | 2023-07-06 | — | — | WO | disclosed |
| US-20230157985-A1 | METHODS FOR TREATMENT OF PARKINSON'S DISEASE | NEURODERM, LTD. (IL) | 2023-05-25 | — | — | US | disclosed |
| CN-114426897-B | Gasoline engine lubricating oil composition and preparation method thereof | 中国石油化工股份有限公司 | 2023-03-10 | — | — | CN | disclosed |
| CN-114426896-B | Lubricating oil composition for diesel engine and preparation method thereof | 中国石油化工股份有限公司 | 2023-03-10 | — | — | CN | disclosed |
| CN-112707819-B | Ester compound and preparation method and application thereof | 中国石油化工股份有限公司 | 2022-12-13 | — | — | CN | disclosed |
| EP-4025200-A1 | LIQUID COMPOSITIONS COMPRISING A LEVODOPA AMINO ACID CONJUGATE AND USES THEREOF | Neuroderm Ltd (IL) | 2022-07-13 | — | — | EP | disclosed |
| CN-114507555-A | Biodegradable flame-retardant hydraulic oil composition | 中国石油化工股份有限公司 | 2022-05-17 | — | — | CN | disclosed |
| CN-114426897-A | Gasoline engine lubricating oil composition and preparation method thereof | 中国石油化工股份有限公司 | 2022-05-03 | — | — | CN | disclosed |
| CN-114426896-A | Lubricating oil composition for diesel engine and preparation method thereof | 中国石油化工股份有限公司 | 2022-05-03 | — | — | CN | disclosed |
| CN-112707819-A | Ester compound and preparation method and application thereof | 中国石油化工股份有限公司 | 2021-04-27 | — | — | CN | disclosed |
| WO-2021044420-A1 | LIQUID COMPOSITIONS COMPRISING A LEVODOPA AMINO ACID CONJUGATE AND USES THEREOF | NEURODERM, LTD. (IL) | 2021-03-11 | — | — | WO | disclosed |
| EP-1924240-A1 | PERSONAL CARE PRODUCTS INCORPORATING CELLULOSIC FATTY ACID ESTERS | EASTMAN CHEMICAL COMPANY (US) | 2008-05-28 | — | — | EP | disclosed |
| WO-2007033252-A1 | PERSONAL CARE PRODUCTS INCORPORATING CELLULOSIC FATTY ACID ESTERS | EASTMAN CHEMICAL COMPANY (US) | 2007-03-22 | — | — | WO | disclosed |
| US-20070053855-A1 | Personal care products incorporating cellulosic fatty acid esters | EASTMAN CHEMICAL COMPANY | 2007-03-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11844754-B2 | Methods for treatment of Parkinson's disease | DDC, DDT, SLC6A3 | TERT 4540/4885PTPN1 2845/4885PPARG 1183/4885 |
| US-20240207410-A1 | STABILIZED LIQUID COMPOSITIONS COMPRISING A LEVODOPA-TYROSINE CONJUGATE AND USES THEREOF | COMT, TH, DDT | TERT 3070/4885PTPN1 188/4885PPARG 2030/4885 |
| US-20230157985-A1 | METHODS FOR TREATMENT OF PARKINSON'S DISEASE | DDC, DDT, COMT | TERT 4517/4885PTPN1 2857/4885PPARG 1179/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.